Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01966757 · ClinicalTrials.gov registry record
Neuronal Ceroid Lipofuscinosis and Associated Sleep Abnormalities
A clinical trial of Batten's Disease and Neuronal Ceroid Lipofuscinosis, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 57
- Enrollment target
- 1
- Study location
NCT01966757 is a study of Batten's Disease and Neuronal Ceroid Lipofuscinosis that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 57 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01966757, a study of Batten's Disease and Neuronal Ceroid Lipofuscinosis, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
Neuronal Ceroid Lipofuscinosis (NCL) also known at Batten's disease is the most common neurodegenerative disorder in children. Families often report the patient has a sleep disturbance. This is a questionnaire to be completed by the family to better understand the sleep pattern and sleep difficulties experienced by individuals who have been diagnosed with NCL.
Conditions Studied
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01966757
The ClinicalTrials.gov registry entry for NCT01966757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Batten's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01966757 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01966757 about?
NCT01966757 is a clinical study titled "Neuronal Ceroid Lipofuscinosis and Associated Sleep Abnormalities". Neuronal Ceroid Lipofuscinosis (NCL) also known at Batten's disease is the most common neurodegenerative disorder in children. Families often report the patient has a sleep disturbance. This is a questionnaire to be completed by the family to better understand the sleep pattern and sleep difficultie...
What is the current status of trial NCT01966757?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2013-07. Estimated completion is 2016-07.
What conditions does trial NCT01966757 study?
This clinical trial studies the following conditions: Batten's Disease, Neuronal Ceroid Lipofuscinosis.
Who is sponsoring clinical trial NCT01966757?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01966757 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Batten's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.